Global Opportunity Analysis and Industry Forecast, 2018–2025, for Sexually Transmitted Diseases (STD) Testing by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, and Others), and Testing Location (Laboratory Testing and Point-of-Care Testing).
From 2018 to 2025, the global STD testing market is expected to rise at a CAGR of 5.6 percent, from $ 86,548.0 million in 2017 to $ 133,935.7 million in 2025.
Sexually transmitted infections are regarded as one of the world's most serious health problems. Sexually transmitted infections such as chlamydia, gonorrhoea, and the herpes simplex virus are all very common. With the rising prevalence of STDs, the STD testing industry has seen substantial expansion in the last decade. Because of the high prevalence of STDs, the number of STD diagnosis facilities has significantly expanded in developed countries. However, STD diagnosis facilities in developing countries are still insufficient.
In the last decade, the frequency and incidence of STDs have increased dramatically. As the prevalence of STDs rises, countries around the world are focusing on implementing nationwide screening programmes to increase STD diagnosis coverage. Furthermore, reimbursement policies for STD services have been beneficial. These reasons are contributing considerably to the worldwide STD testing market's expansion. Limited access to STD diagnosis in underdeveloped nations, on the other hand, is projected to impede market expansion.
The global STD testing market is divided into three categories: illness type, testing location, and geography. It is divided into chlamydia, syphilis, gonorrhoea, herpes simplex virus, human papillomavirus, human immunodeficiency virus tests, and others based on illness type. The market is divided into two categories based on the site of testing: laboratory testing and point of care (PoC) testing. The market is divided into four regions: North America, Europe, Asia-Pacific, and Latin America and the Caribbean.
According to illness kind, the chlamydia segment generates the most income, while gonorrhoea is predicted to expand at the fastest pace of 8.9%. This is due to an increase in the prevalence of gonorrhoea over the last ten years.
In 2017, the laboratory testing segment accounted for the biggest proportion of the STD testing market by site of testing. During the projected period, the POC testing segment is expected to increase at the fastest rate. Factors such as speedier diagnosis with POC tests and the predicted rise in POC use in the future all contribute to the segment's growth.
This research includes a quantitative analysis as well as a strategic review of the current global STD testing market trends from 2017 to 2025 in order to discover the prevailing opportunities.
From 2018 to 2025, the global STD testing market is forecasted.
The global STD testing market size and forecasts are based on a thorough examination of significant industry developments.
Strategic company planning is made easier with a qualitative analysis based on creative items.
The leading market players' development strategies are enumerated in order to comprehend the market's competitive landscape.
Comments
Post a Comment